Smooth Podcasting is the producer of our podcast. They help us deliver high quality audio, show notes, transcripts, podcast marketing, and so much more. We totally recommend them!
About Steve Chapman
Steve is Natera’s Chief Executive Officer and serves on the company’s Board of Directors. Mr. Chapman joined Natera in 2010 as the Vice President of Sales, later becoming Chief Commercial Officer and then Chief Operating Officer. As COO, he led the company’s commercial entry into the highly competitive, non-invasive prenatal testing market in which the company’s panorama test became the market leader despite being fourth to market. Mr. Chapman was appointed CEO in January of 2019 and has been instrumental in extending the terrorist core technology to address new organ health and oncology markets, achieving rapid commercial growth for the Prospera transplant assessment test and establishing Natera’s leadership in molecular residual disease testing with another product they have called Signatera. Since he became CEO of Natera, Natera’s achieved year-on-year revenue growth of over 40 percent and has consistently outperformed earnings expectations. Prior to Natera, Mr. Chapman worked at Genzyme Genetics, where he was credited with delivering record-breaking commercial growth and strategies that change pregnancy genetic testing.
Things You’ll Learn